Standout Papers
- Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma (2011)
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial (2012)
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy (2013)
- Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 (2019)
- Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma (2011)
- Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance (2012)
- BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact (2014)
Immediate Impact
9 by Nobel laureates 22 from Science/Nature 90 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Cutaneous melanoma
2023 Standout
Works of Richard Kefford being referenced
Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma
2016
Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Richard Kefford | 13685 | 11485 | 3916 | 353 | 20.1k | |
| Grant A. McArthur | 14701 | 14988 | 3713 | 388 | 26.3k | |
| Paolo A. Ascierto | 17638 | 11139 | 6919 | 744 | 24.4k | |
| Peter Hersey | 9944 | 10633 | 7088 | 347 | 19.9k | |
| Patricia LoRusso | 10965 | 10660 | 1915 | 560 | 21.3k | |
| Jeffrey A. Sosman | 15916 | 15337 | 6817 | 343 | 28.0k | |
| Georgina V. Long | 24765 | 16231 | 8971 | 669 | 33.3k | |
| Igor Puzanov | 10021 | 6732 | 3784 | 300 | 15.1k | |
| David B. Solit | 10407 | 15386 | 2361 | 358 | 25.6k | |
| Alexander M.M. Eggermont | 18119 | 9231 | 6568 | 386 | 25.1k | |
| Michael A. Davies | 6861 | 7629 | 1866 | 315 | 12.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...